Company Filing History:
Years Active: 2025
Title: Innovations of Xiaobo Xi in Vaccine Development
Introduction
Xiaobo Xi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly through his innovative approach to microcapsule-based vaccines. His work is characterized by a focus on creating effective and efficient delivery systems for antigens.
Latest Patents
Xiaobo Xi holds a patent for a microcapsule-based vaccine. This vaccine comprises an antigen and a matrix of biodegradable polymer blend. The polymer blend includes a hydrophobic polymer and an amphiphilic block copolymer. The vaccine is designed in the form of microcapsules that feature a multi-cavity structure inside. The average particle diameter of the microcapsules is preferably between 10-100 μm, with a more specific preference for 30-60 μm. The preparation method involves creating porous microspheres from the polymer blend, mixing these microspheres with an antigen-containing solution, and sealing the openings of the microspheres to form an opening-sealed microcapsule loaded with the antigen. This innovative approach enhances the efficacy of the vaccine.
Career Highlights
Xiaobo Xi is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His career is marked by a commitment to advancing vaccine technology and improving public health outcomes through innovative solutions.
Collaborations
Xiaobo Xi collaborates with notable colleagues, including Guanghui Ma and Wei Wei. These partnerships enhance the research and development process, fostering a collaborative environment that drives innovation.
Conclusion
Xiaobo Xi's contributions to vaccine development through his microcapsule-based vaccine patent exemplify the importance of innovation in healthcare. His work not only showcases his expertise but also highlights the potential for advancements in vaccine technology to improve health outcomes globally.